Anesthesia Pharmacology Chapter 27: Gastrointestinal Pharmacology Practice Questions

Inflammatory bowel disease (IBD): subtype(s)
1. Crohn's disease
2. Ulcerative colitis
3. Both
4. Neither
"Confluent mucosal inflammation" of the colon, starting at the anal verge.
1. Ulcerative colitis
2. Crohn's disease
"Transmural inflammation" localized at any part of the G.I. tract, most frequently adjacent to the ileocecal valve.
1. Crohn's disease
2. Ulcerative colitis
Primary sclerosing cholangitis, serious yet infrequent complication associated with:
1. Crohn's disease
2. Ulcerative colitis
Severe inflammatory bowel disease when present chronically confers enhance risk for colorectal cancer development.
1. True
2. False
Lesions exhibit lymphocyte infiltration, macrophage infiltration, granuloma and submucosal fibrosis:
1. Crohn's disease
2. Ulcerative colitis
Lesions are characterized by lymphocytic neutrophilic infiltrates:
1. Crohn's disease
2. Ulcerative colitis
Crohn's disease and ulcerative colitis appear related to an abnormal immune response to commensal "microbiota" of the gut (in genetically susceptible people).
1. True
2. False
Most drugs considered effective in management of IBD exhibit specific mechanisms of anti-inflammatory action.
1. True
2. False
Selecting appropriate treatment for inflammatory bowel disease takes into account:
1. Disease severity
2. Responsiveness to treatment
3. Both
4. Neither

Anesthesia Pharmacology: Gastrointestinal Pharmacology Practice Questions